题名 | Long-term effects of simultaneous subconjunctival and subscleral mitomycin C application in repeat trabeculectomy |
作者 | |
发表日期 | 2002-04 |
发表期刊 | JOURNAL OF GLAUCOMA 影响因子和分区 |
语种 | 英语 |
原始文献类型 | Article |
关键词 | mitomycin trabeculectomy glaucoma |
其他关键词 | GLAUCOMA FILTRATION SURGERY ; FILTERING SURGERY ; POSTOPERATIVE 5-FLUOROURACIL ; INTRAOPERATIVE MITOMYCIN ; AQUEOUS-HUMOR ; RABBIT ; FIBROBLASTS |
摘要 | Purpose: To assess the efficacy and safety of simultaneous mitomycin C application under conjunctival and scleral flaps in patients with repeat trabeculectomy. Methods: A total of 44 patients (44 eyes) with previous failed filtering surgery were randomized to one of two groups. The both-flaps group comprised 22 patients (22 eyes) with trabeculectomy and intraoperative mitomycin C application under conjunctival and scleral flaps, whereas the subconjunctival group comprised 22 patients (22 eyes) with subconjunctival application of mitomycin C. Particular attention was paid to intraocular pressure, postoperative medications, visual acuity, filtering bleb appearance, and complications. The mean follow-up time was 38.18 +/- 12.48 months. Results: The mean preoperative intraocular pressure decreased from 39.1 +/- 7.3 mm Hg to the postoperative level of 15.6 +/- 4.8 mm Hg in the both-flaps group (P = 0.014), and from 39.4 +/- 8.4 to 18.7 +/- 5.8 mm Hg in the subconjunctival group (P = 0.018). There was a statistically significant difference in intraocular pressure at all follow-up times, except at 1 week and 1 month postoperatively. Kaplan-Meier survival analysis showed there was no significant difference in total success rate (complete plus qualified success) between the two group, (P = 0.622, log-rank test). However, the two survival curves for the complete success subgroups (without additional medications) confirmed that mitomycin C applications under both flaps had a higher success rate than subconjunctival application (P = 0.043, log-rank test). No statistically significant difference in medications was present between the two groups, and no severe complications developed in either group. Conclusions: Trabeculectomy augmented with mitomycin C application at both sites could produce a greater lowering of intraocular pressure with low incidence of postoperative complications, and could provide an increased chance of long-term success. The procedure is effective and safe in patients with repeat trabeculectomy. |
出版者 | LIPPINCOTT WILLIAMS & WILKINS |
出版地 | PHILADELPHIA |
ISSN | 1057-0829 |
卷号 | 11期号:2页码:110-118 |
DOI | 10.1097/00061198-200204000-00006 |
页数 | 9 |
WOS类目 | Ophthalmology |
WOS研究方向 | Ophthalmology |
WOS记录号 | WOS:000174913000006 |
收录类别 | SCIE ; PUBMED ; SCOPUS |
URL | 查看原文 |
PubMed ID | 11912358 |
SCOPUSEID | 2-s2.0-0036213912 |
通讯作者地址 | [You, YA]First Affiliated Hosp, Dept Ophthalmol, Wenzhou Med Coll, Wenzhou 325000, Zhejiang, Peoples R China. |
引用统计 | |
文献类型 | 期刊论文 |
条目标识符 | https://kms.wmu.edu.cn/handle/3ETUA0LF/3927 |
专题 | 附属第一医院_眼科 |
通讯作者 | You, YA |
作者单位 | 1.First Affiliated Hosp, Dept Ophthalmol, Wenzhou Med Coll, Wenzhou 325000, Zhejiang, Peoples R China; 2.Zhejiang Univ, Coll Med, Dept Ophthalmol, Affiliated Hosp 1, Hangzhou 310027, Zhejiang, Peoples R China |
通讯作者单位 | 眼科 |
推荐引用方式 GB/T 7714 | You, YA,Gu, YS,Fang, CT,et al. Long-term effects of simultaneous subconjunctival and subscleral mitomycin C application in repeat trabeculectomy[J]. JOURNAL OF GLAUCOMA,2002,11(2):110-118. |
APA | You, YA, Gu, YS, Fang, CT, & Ma, XQ. (2002). Long-term effects of simultaneous subconjunctival and subscleral mitomycin C application in repeat trabeculectomy. JOURNAL OF GLAUCOMA, 11(2), 110-118. |
MLA | You, YA,et al."Long-term effects of simultaneous subconjunctival and subscleral mitomycin C application in repeat trabeculectomy".JOURNAL OF GLAUCOMA 11.2(2002):110-118. |
条目包含的文件 | 条目无相关文件。 |
个性服务 |
查看访问统计 |
谷歌学术 |
谷歌学术中相似的文章 |
[You, YA]的文章 |
[Gu, YS]的文章 |
[Fang, CT]的文章 |
百度学术 |
百度学术中相似的文章 |
[You, YA]的文章 |
[Gu, YS]的文章 |
[Fang, CT]的文章 |
必应学术 |
必应学术中相似的文章 |
[You, YA]的文章 |
[Gu, YS]的文章 |
[Fang, CT]的文章 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论